Journals / Klinik Psikofarmakoloji Bülteni / 2009 / Cilt: 19 - Sayı: 1

Sinus tachycardia during quetiapine therapy: Three case reports

Ketiapin kullanımı sırasında ortaya çıkan sinüs taşikardisi: Üç olgu sunumu

Pages
55–58
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Three patients who developed sinus tachycardia during quetiapine therapy are presented in this case report.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Quetiapine, a dibenzothiazepine derivative, is an atypical antipsychotic, multireceptor antagonist that has a preclinical profile similar to clozapine.
📊
Key Findings & Data:Randomized studies have demonstrated the efficacy of quetiapine relative to placebo in the treatment of acute relapse and the longterm management of schizophrenia.
💡
Conclusion & Impact:Three patients who developed sinus tachycardia during quetiapine therapy are presented in this case report.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Quetiapine, a dibenzothiazepine derivative, is an atypical antipsychotic, multireceptor antagonist that has a preclinical profile similar to clozapine. Randomized studies have demonstrated the efficacy of quetiapine relative to placebo in the treatment of acute relapse and the longterm management of schizophrenia. Quetiapine is generally well tolerated relative to other antipsychotic medications, although sedation, orthostatic hypotension, anticholinergic and metabolic side effects were reported. Three patients who developed sinus tachycardia during quetiapine therapy are presented in this case report.

Özet

Ketiapin, yapısı klozapine benzeyen ve çok sayıda reseptörün antagonisti olan dibenzodiazepin türevi bir atipik antipsikotiktir. fiizofreninin uzun dönem tedavisi ve akut alevlenmelerin tedavisinde ketiapin’in plaseboya göre etkinliği randomize çalışmalarda gösterilmiştir. Ketiapin, diğer antipsikotik tedavilere göre genellikle iyi tolere edilmesine rağmen, sedasyon, ortostatik hipotansiyon, antikolinerjik ve metabolik yan etkileri içermektedir. Bu yazıda, ketiapin kullanımı sırasında sinus taşikardisi ortaya çıkan 3 olgu sunulmuştur

🔖

Cite This Article

KANDEMİR, G., HIDIROĞLU, H., HOCAOĞLU, Ç. (2022). Sinus tachycardia during quetiapine therapy: Three case reports. Klinik Psikofarmakoloji Bülteni, Cilt: 19 - Sayı: 1, 55–58. https://ajindex.com/articles/574248

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Hustey F. Acute Quetiapine Poisoning. J Emerg Med 1999; 17: 995-997 2. Balit RC, Isbister GK, Hackett LP, Whyte IM. Quetiapine Poisoning: A case Series. Ann Emerg Med 2003;42: 752-758 3. İlhan A, Özcan ME, Tuncer C, Kalı S, Boztepe AV, Pekdemir H. Antipsikotik kullanımının ventriküler repolarizasyon parametreleri üzerine etkileri. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 1999; 9:112-117 4. Memik NÇ, Tural Ü, Önder ME. Ketiapin ile ilişkili olan sinüs taşikardisi Psikiyatri Psikoloji Psikofarmakoloji (3P) Dergisi 2003; 11:235-239 5. Saka MC, Can S, Özgüven HD, Atbaşoğlu EC. Antipsikotik İlaçların Yan Etkileri Türkiye Klinikleri Dahili Tıp Bilimleri Dergisi Psikiyatri 2005; 1: 58-66 6. Miodownik C, Lerner V.Quetiapine: efficacy, tolerability and safety in schizophrenia. Expert Rev Neurother 2006; 6: 983-992 7. Farah A. What is an atypical antipsychotic? Prim Care Companion J Clin Psychiatry 2005; 7: 268-274 8. Pollack PT, Zbuk K. Quetiapine Fumarate overdose: Clinical and pharmacokinetic lessons from extreme conditions. Clin Pharmacol Ther 2000; 68: 92-97 9. Gajwani P, Pozuelo L, Tesar GE. QT interval prolongation associated with quatiapine overdose. Psychosomatics 2000; 41:63-65 10. Buckley NA, Sanders P. Cardiovasculer advers effects of antipsychotics drugs. Drug Saf 2000; 23: 215-228 11. Dev V, Raniwalla J. Quetiapine: a review of its safety in the management of schizophrenia. Drug Saf 2000; 23: 295-307